WallStreetZenWallStreetZen

NASDAQ: EWTX
Edgewise Therapeutics Inc Stock Ownership - Who owns Edgewise Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Edgewise Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joanne M. DonovanCMO2026-08-132,919$43.41
$126.71kSell
Joanne M. DonovanCMO2026-08-132,919$43.41
$126.71kSell
Behrad DerakhshanCXO2026-08-12150$44.44
$6.67kSell
Behrad DerakhshanCXO2026-08-122,475$43.70
$108.15kSell
Behrad DerakhshanCXO2026-08-122,171$43.79
$95.07kSell
Behrad DerakhshanCXO2026-08-12304$44.50
$13.53kSell
Behrad DerakhshanCXO2026-08-12150$44.44
$6.67kSell
Behrad DerakhshanCXO2026-08-122,475$43.70
$108.15kSell
Behrad DerakhshanCXO2026-08-122,171$43.79
$95.07kSell
Behrad DerakhshanCXO2026-08-12304$44.50
$13.53kSell

1 of 7

EWTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when EWTX insiders and whales buy or sell their stock.

EWTX Shareholders

What type of owners hold Edgewise Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Holdings A. Novo5.59%6,071,703$275.90MInsider
James E. Flynn3.62%3,933,137$178.72MInsider
Jonathan D. Root3.21%3,489,168$158.55MInsider
Wellington Biomedical Innovation Master Investors Cayman I LP0.63%681,812$30.98MInsider
Orbimed Advisors LLC0.41%443,792$20.17MInsider
Peter A. Thompson0.41%443,792$20.17MInsider
Kevin Koch0.38%417,682$18.98MInsider
R. Michael Carruthers0.08%86,162$3.92MInsider
Behrad Derakhshan0.03%31,826$1.45MInsider
Alan J. Russell0.03%31,466$1.43MInsider

1 of 3

EWTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
EWTX0.11%14.46%Net SellingNet Selling
PBLS0.08%6.36%Net BuyingNet Buying
DFTX0.09%35.42%Net SellingNet Selling
ERAS0.08%24.59%Net Buying
ACAD0.10%37.54%Net SellingNet Selling
View Top Biotech Stocks

Edgewise Therapeutics Stock Ownership FAQ

Who owns Edgewise Therapeutics?

Edgewise Therapeutics (NASDAQ: EWTX) is owned by 0.11% institutional shareholders, 14.46% Edgewise Therapeutics insiders, and 85.43% retail investors. Holdings A. Novo is the largest individual Edgewise Therapeutics shareholder, owning 6.07M shares representing 5.59% of the company. Holdings A. Novo's Edgewise Therapeutics shares are currently valued at $285.01M.

If you're new to stock investing, here's how to buy Edgewise Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.